Drug Overdose Investigation Fund Initiative
The mission of the Oregon-Idaho HIDTA Drug Overdose Investigation Fund initiative is to aggressively investigate drug overdose fatalities and serious physical injuries by identifying, targeting, arresting and prosecuting the individuals and organizations responsible for providing the controlled substances that resulted in the death or serious physical injury of a person.
This support initiative will provide funding to existing Oregon-Idaho HIDTA initiatives that initiate and conduct investigations that focus on identifying, arresting and prosecuting individuals and disrupting or dismantling drug trafficking organizations (DTO) that have provided controlled substances which have resulted in the death or serious physical injury of another person. Funding obtained through this initiative will be used to offset overtime, investigative travel, services and PE/PI expenses that are incurred by the initiatives during the course of their investigation. Funding will be provided to Oregon-Idaho HIDTA initiatives through an application, reprogramming and reimbursement process that is administered by the Oregon-Idaho HIDTA Director and the Oregon-Idaho HIDTA Executive Board Finance Committee. These funds are not intended to be used to offset expenses arising directly from the initial death or assault investigation.
The strategy employed by Oregon-Idaho HIDTA initiatives that apply for these funds should involve an immediate response to drug overdose scenes, where the victim has died or incurred serious physical injury, in order to collect any and all physical evidence that may help to identify the individual and/or DTO that supplied the controlled substances that led to the overdose. This investigative strategy has proven to be highly effective and, as the result of enhanced penalties within federal law commonly referred to as the “Len Bias Law”, has enabled investigators to investigate up the drug supply chain which has resulted in the identification, disruption and dismantlement of several sophisticated heroin DTOs.
Oregon-Idaho HIDTA task forces that receive funding from this initiative will be required to actively pursue prosecution at the state or federal level. Oregon-Idaho HIDTA task forces that receive funding from this initiative will deconflict and share case related information with the Oregon-Idaho HIDTA ISC and other law enforcement agencies as appropriate. Oregon-Idaho HIDTA task forces that receive funding from this initiative will report all performance statistics in the HIDTA Performance Management Program (PMP) database and will provide a case recap to the ISC at the conclusion of the investigation.
Funding to cover agreed upon costs will be reprogrammed from this initiative to the recipient Oregon-Idaho HIDTA initiative upon receipt and approval of reimbursement requests by the Oregon-Idaho HIDTA Management and Administration Initiative. Reimbursement from this initiative will not exceed $7500 for any single case and reimbursement for expenses arising directly from the initial death or assault investigation will not be authorized.
Oregon-Idaho HIDTA initiatives that wish to apply for funding are required to complete and submit an Oregon-Idaho HIDTA Investigation Fund application in a “reasonable period of time” (approximately 5 business days) after initiating the overdose investigation. Completed applications will be evaluated and decided upon by the Oregon-Idaho HIDTA Executive Board Finance Committee within 3 days of receipt. Award notifications will be made in writing within 2 business days of the Finance Committee’s decision.
Upon completion of the investigation, the HIDTA initiative is required to download, complete and return an Oregon-Idaho HIDTA Investigative Fund Outcome Report to the Oregon-Idaho HIDTA Investigative Support Center.